- Home
- ILAG vs CARM Comparison
ILAG vs CARM Comparison
Compare ILAG & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILAG
- CARM
- Stock Information
- Founded
- ILAG 1981
- CARM 2016
- Country
- ILAG Hong Kong
- CARM United States
- Employees
- ILAG N/A
- CARM N/A
- Industry
- ILAG Office Equipment/Supplies/Services
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- ILAG Consumer Discretionary
- CARM Health Care
- Exchange
- ILAG Nasdaq
- CARM Nasdaq
- Market Cap
- ILAG 10.7M
- CARM 12.2M
- IPO Year
- ILAG 2022
- CARM N/A
- Fundamental
- Price
- ILAG $0.55
- CARM $0.24
- Analyst Decision
- ILAG
- CARM Hold
- Analyst Count
- ILAG 0
- CARM 5
- Target Price
- ILAG N/A
- CARM $0.90
- AVG Volume (30 Days)
- ILAG 250.7K
- CARM 443.1K
- Earning Date
- ILAG 04-28-2025
- CARM 08-07-2025
- Dividend Yield
- ILAG N/A
- CARM N/A
- EPS Growth
- ILAG N/A
- CARM N/A
- EPS
- ILAG N/A
- CARM N/A
- Revenue
- ILAG $7,506,551.00
- CARM $10,767,000.00
- Revenue This Year
- ILAG N/A
- CARM N/A
- Revenue Next Year
- ILAG N/A
- CARM N/A
- P/E Ratio
- ILAG N/A
- CARM N/A
- Revenue Growth
- ILAG 16.50
- CARM N/A
- 52 Week Low
- ILAG $0.34
- CARM $0.14
- 52 Week High
- ILAG $1.35
- CARM $1.27
- Technical
- Relative Strength Index (RSI)
- ILAG 56.14
- CARM 31.94
- Support Level
- ILAG $0.50
- CARM $0.21
- Resistance Level
- ILAG $0.60
- CARM $0.31
- Average True Range (ATR)
- ILAG 0.05
- CARM 0.03
- MACD
- ILAG 0.00
- CARM -0.00
- Stochastic Oscillator
- ILAG 41.14
- CARM 23.64
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.